Applied Therapeutics, INC Form 4 insider transactions

Riccardo Perfetti, Chief Medical Officer of Applied Therapeutics, sold 22,003 shares of common stock to cover tax withholding obligations related to the vesting and settlement of compensatory Restricted Stock Units.

Leslie D. Funtleyder, CFO of Applied Therapeutics, Inc., sold 16,980 shares of common stock on June 6, 2024, to cover tax withholding obligations related to the vesting and settlement of compensatory Restricted Stock Units.

Director Stacy J. Kanter acquired 45,000 shares of Applied Therapeutics, Inc. common stock on June 6, 2024, through compensatory Restricted Stock Units.

Director Jay Skyler S acquired 45,000 shares of Applied Therapeutics common stock on June 6, 2024, as part of a compensatory Restricted Stock Unit grant.

Director Joel S. Marcus acquired 45,000 shares of Applied Therapeutics, Inc. common stock on June 6, 2024, through compensatory Restricted Stock Units.

Director Teena Lerner acquired 45,000 shares of Applied Therapeutics common stock in the form of restricted stock units on June 6, 2024.

Alexandria Real Estate Equities, a significant shareholder of Applied Therapeutics, has sold a portion of its common stock holdings through its subsidiaries.

Corwin Dale Hooks, Chief Commercial Officer of Applied Therapeutics, Inc., was granted 300,000 compensatory Restricted Stock Units on April 12, 2024, under the company's 2019 Equity Incentive Plan.

Shoshana Shendelman, CEO of Applied Therapeutics, sold shares to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Riccardo Perfetti, Chief Medical Officer of Applied Therapeutics, sold 110,804 shares of common stock to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Adam Hansard, Chief Commercial Officer of Applied Therapeutics, sold 48,871 shares of common stock on March 14, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Leslie D. Funtleyder, CFO of Applied Therapeutics, sold 28,727 shares of common stock to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Constantine Chinoporos, Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc., was granted 300,000 compensatory Restricted Stock Units (RSUs) on December 28, 2023.